Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.

Tytuł:
Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.
Autorzy:
Monet-Leprêtre M; INSERM, U740, Paris, F-75010, France.
Haddad I
Baron-Menguy C
Fouillot-Panchal M
Riani M
Domenga-Denier V
Dussaule C
Cognat E
Vinh J
Joutel A
Źródło:
Brain : a journal of neurology [Brain] 2013 Jun; Vol. 136 (Pt 6), pp. 1830-45. Date of Electronic Publication: 2013 May 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Oxford : Oxford University Press
Original Publication: London.
MeSH Terms:
CADASIL/*diagnosis
CADASIL/*metabolism
Extracellular Matrix Proteins/*metabolism
Receptors, Notch/*metabolism
Tissue Inhibitor of Metalloproteinase-3/*metabolism
Aged ; Aged, 80 and over ; Animals ; CADASIL/genetics ; Cells, Cultured ; Disease Models, Animal ; Extracellular Matrix Proteins/genetics ; Female ; Homeostasis/genetics ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Middle Aged ; Protein Transport/genetics ; Receptor, Notch3 ; Receptors, Notch/genetics ; Tissue Inhibitor of Metalloproteinase-3/genetics
References:
Lancet Neurol. 2009 Jul;8(7):643-53. (PMID: 19539236)
Semin Thromb Hemost. 2011 Jun;37(4):408-24. (PMID: 21805447)
Cardiovasc Res. 2006 Feb 15;69(3):562-73. (PMID: 16405877)
Acta Neuropathol. 2006 Sep;112(3):333-9. (PMID: 16871402)
Nat Med. 2003 Apr;9(4):407-15. (PMID: 12652295)
Acta Neuropathol. 1995;89(6):500-12. (PMID: 7676806)
Cell. 2009 Apr 17;137(2):216-33. (PMID: 19379690)
J Clin Invest. 2000 Mar;105(5):597-605. (PMID: 10712431)
Blood. 2010 Nov 25;116(22):4720-30. (PMID: 20739660)
Am J Pathol. 2003 Jan;162(1):329-42. (PMID: 12507916)
Brain. 2009 Apr;132(Pt 4):933-9. (PMID: 19174371)
Semin Cell Dev Biol. 2011 Jul;22(5):476-81. (PMID: 21458579)
Genes Dev. 2004 Nov 15;18(22):2730-5. (PMID: 15545631)
Brain. 2009 Jun;132(Pt 6):1601-12. (PMID: 19293235)
Cell. 2011 Jan 7;144(1):67-78. (PMID: 21215370)
J Clin Invest. 2010 Feb;120(2):433-45. (PMID: 20071773)
Arch Neurol. 2005 Jul;62(7):1091-4. (PMID: 16009764)
Hum Mol Genet. 2011 Aug 15;20(16):3256-65. (PMID: 21628316)
Nature. 1996 Oct 24;383(6602):707-10. (PMID: 8878478)
Circ Res. 2010 Oct 1;107(7):860-70. (PMID: 20689064)
Acta Neuropathol. 2003 Aug;106(2):107-11. (PMID: 12756589)
Hum Mol Genet. 2009 Aug 1;18(15):2761-7. (PMID: 19417009)
Anal Biochem. 2001 Sep 15;296(2):279-83. (PMID: 11554724)
Am J Hum Genet. 2004 Feb;74(2):338-47. (PMID: 14714274)
Cardiovasc Res. 2012 Jul 15;95(2):138-46. (PMID: 22266753)
Exp Cell Res. 2004 Oct 1;299(2):454-64. (PMID: 15350543)
Lancet Neurol. 2010 Jul;9(7):689-701. (PMID: 20610345)
Lancet. 1997 Nov 22;350(9090):1511-5. (PMID: 9388399)
Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6117-23. (PMID: 21282576)
Br J Ophthalmol. 1998 Nov;82(11):1329-34. (PMID: 9924344)
Anal Chem. 2004 Jul 15;76(14):4193-201. (PMID: 15253663)
Hum Mol Genet. 2007 Apr 15;16(8):982-92. (PMID: 17331978)
Sci Signal. 2008 Jul 08;1(27):re6. (PMID: 18612141)
Brain Res. 2012 May 25;1456:64-71. (PMID: 22503071)
Nat Genet. 1994 Dec;8(4):352-6. (PMID: 7894485)
J Biol Chem. 2007 Mar 2;282(9):6887-98. (PMID: 17202148)
Lancet Neurol. 2007 Feb;6(2):149-61. (PMID: 17239802)
Proc Natl Acad Sci U S A. 2011 May 24;108(21):E128-35. (PMID: 21555590)
Brain Res. 2007 Feb 23;1134(1):1-11. (PMID: 17196184)
Lancet. 2001 Dec 15;358(9298):2049-51. (PMID: 11755616)
Grant Information:
R01 NS054122 United States NS NINDS NIH HHS
Contributed Indexing:
Keywords: CADASIL; Notch3; cerebrovasculature; extracellular matrix proteins; protein aggregation
Substance Nomenclature:
0 (Extracellular Matrix Proteins)
0 (NOTCH3 protein, human)
0 (Receptor, Notch3)
0 (Receptors, Notch)
0 (TIMP3 protein, human)
0 (Tissue Inhibitor of Metalloproteinase-3)
Entry Date(s):
Date Created: 20130508 Date Completed: 20130807 Latest Revision: 20220318
Update Code:
20240104
PubMed Central ID:
PMC3673461
DOI:
10.1093/brain/awt092
PMID:
23649698
Czasopismo naukowe
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, or CADASIL, one of the most common inherited small vessel diseases of the brain, is characterized by a progressive loss of vascular smooth muscle cells and extracellular matrix accumulation. The disease is caused by highly stereotyped mutations within the extracellular domain of the NOTCH3 receptor (Notch3(ECD)) that result in an odd number of cysteine residues. While CADASIL-associated NOTCH3 mutations differentially affect NOTCH3 receptor function and activity, they all are associated with early accumulation of Notch3(ECD)-containing aggregates in small vessels. We still lack mechanistic explanation to link NOTCH3 mutations with small vessel pathology. Herein, we hypothesized that excess Notch3(ECD) could recruit and sequester functionally important proteins within small vessels of the brain. We performed biochemical, nano-liquid chromatography-tandem mass spectrometry and immunohistochemical analyses, using cerebral and arterial tissue derived from patients with CADASIL and mouse models of CADASIL that exhibit vascular lesions in the end- and early-stage of the disease, respectively. Biochemical fractionation of brain and artery samples demonstrated that mutant Notch3(ECD) accumulates in disulphide cross-linked detergent-insoluble aggregates in mice and patients with CADASIL. Further proteomic and immunohistochemical analyses identified two functionally important extracellular matrix proteins, tissue inhibitor of metalloproteinases 3 (TIMP3) and vitronectin (VTN) that are sequestered into Notch3(ECD)-containing aggregates. Using cultured cells, we show that increased levels or aggregation of Notch3 enhances the formation of Notch3(ECD)-TIMP3 complex, promoting TIMP3 recruitment and accumulation. In turn, TIMP3 promotes complex formation including NOTCH3 and VTN. In vivo, brain vessels from mice and patients with CADASIL exhibit elevated levels of both insoluble cross-linked and soluble TIMP3 species. Moreover, reverse zymography assays show a significant elevation of TIMP3 activity in the brain vessels from mice and patients with CADASIL. Collectively, our findings lend support to a Notch3(ECD) cascade hypothesis in CADASIL disease pathology, which posits that aggregation/accumulation of Notch3(ECD) in the brain vessels is a central event, promoting the abnormal recruitment of functionally important extracellular matrix proteins that may ultimately cause multifactorial toxicity. Specifically, our results suggest a dysregulation of TIMP3 activity, which could contribute to mutant Notch3(ECD) toxicity by impairing extracellular matrix homeostasis in small vessels.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies